focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Yes.
We can anticipate plenty milestones.
Eastman on commercial launch of Cedroz
Bayer on commercial launch of CAP
Sustaine - I expect plenty, but when?
Probably not for field trials - as the majors will pay for all the regulatory costs (?)
Nevertheless, I expect plenty products in the future saying "Sustaine outside".
Expect mega licence fees from sustaine in my view
Sorry Wkevjw, no slur on anyone was intended. Nor was I suggesting that you were not entitled to query this transaction. And yes there are indeed lots of weird goings on that I can't follow/understand. Mind you I have found that to be the case with so many shares. Cheers
In case anyone is interested in NEX trade exchange then simply Google NEX exchange. I never find it easy but eventually you can get to Eden and see Eden trades etc. NEX is particularly good in that it shows the sp when Eden was on the Plus market before it moved to AIM. If you go back far enough you can see the sp topped out at circa 70p. I bought lots at 69 p. What a plonker eh?
Good link. I noticed that while total hectares under cultivation had decreased, litres produced had increased markedly and the value had increased by more than 100% since 2001. That suggests to me that the value of the crop in a hectare has increased significantly making growers more inclined to protect their valuable produce with an efficient pesticide.
3AEY is produced from natural compounds, so is not artificial like the majority of pesticides. However, it cannot as yet be marketed as organic. I think it is due to it being synthetically produced. I'm sure someone will correct any mistake on my part.
I have yet to receive a response from Walbrook regarding why we have a tweet and photograph of despatches to France on Friday yet the Annual Report states commercialisation pending. From looking at the accounts it appears that Eden makes a substantial margin on product sales. This should generate substantial amounts to the bottom line if sales continue as suggested. I also think Terpene Tech could make a worthwhile contribution to profit in the current year - Sean expects sales this year. Equity accounting for TT this year ought to enhance profits. I think we are moving forward and when the market sees Eden generating worthwhile revenues then the sp shoudl react favourably.